| Cancer-related molecular mechanisms research | Lifetime | 10 | CN 4 | 99.91 |
| RNA modifications and cancer | Lifetime | 22 | CN 1 | 99.90 |
| MicroRNA in disease regulation | Lifetime | 32 | CN 8 | 99.78 |
| Epigenetics and DNA Methylation | Lifetime | 51 | CN 2 | 99.78 |
| Genomics and Phylogenetic Studies | Lifetime | 37 | CN 4 | 99.82 |
| Cancer-related gene regulation | Lifetime | 52 | CN 3 | 99.55 |
| Chromosomal and Genetic Variations | Lifetime | 41 | CN 4 | 99.52 |
| Circular RNAs in diseases | Lifetime | 63 | CN 31 | 99.32 |
| Gut microbiota and health | Lifetime | 111 | CN 10 | 99.58 |
| RNA Research and Splicing | Lifetime | 147 | CN 5 | 99.37 |
| RNA and protein synthesis mechanisms | Lifetime | 227 | CN 9 | 99.42 |
| Molecular Biology Techniques and Applications | Lifetime | 143 | CN 4 | 98.60 |
| Metabolomics and Mass Spectrometry Studies | Lifetime | 234 | CN 18 | 98.51 |
| Mycobacterium research and diagnosis | Lifetime | 235 | CN 4 | 98.62 |
| CRISPR and Genetic Engineering | Lifetime | 355 | CN 18 | 98.66 |
| Cancer Genomics and Diagnostics | Lifetime | 667 | CN 12 | 98.79 |
| Hippo pathway signaling and YAP/TAZ | Lifetime | 77 | CN 4 | 97.84 |
| Aquaculture disease management and microbiota | Lifetime | 326 | CN 55 | 98.35 |
| Tuberculosis Research and Epidemiology | Lifetime | 437 | CN 10 | 98.40 |
| Cancer, Hypoxia, and Metabolism | Lifetime | 855 | CN 48 | 97.99 |
| RNA regulation and disease | Lifetime | 243 | CN 8 | 97.69 |
| Genetic Mapping and Diversity in Plants and Animals | Lifetime | 336 | CN 33 | 98.17 |
| Ferroptosis and cancer prognosis | Lifetime | 329 | CN 161 | 96.31 |
| Genomics and Rare Diseases | Lifetime | 281 | CN 6 | 97.47 |
| GABA and Rice Research | Lifetime | 295 | CN 70 | 96.85 |
| Genomic variations and chromosomal abnormalities | Lifetime | 416 | CN 11 | 97.21 |
| Protein Degradation and Inhibitors | Lifetime | 447 | CN 18 | 96.69 |
| Identification and Quantification in Food | Lifetime | 572 | CN 34 | 96.38 |
| Microbial Natural Products and Biosynthesis | Lifetime | 630 | CN 84 | 96.64 |
| Genetics and Neurodevelopmental Disorders | Lifetime | 891 | CN 14 | 96.18 |
| Plant Molecular Biology Research | Lifetime | 956 | CN 163 | 97.10 |
| Congenital heart defects research | Lifetime | 595 | CN 15 | 95.91 |
| Infectious Diseases and Tuberculosis | Lifetime | 830 | CN 25 | 94.20 |
| Machine Learning in Bioinformatics | Lifetime | 392 | CN 98 | 94.87 |
| Signaling Pathways in Disease | Lifetime | 675 | CN 36 | 93.97 |
| Bone Tumor Diagnosis and Treatments | Lifetime | 1,000 | CN 26 | 94.56 |
| Ginseng Biological Effects and Applications | Lifetime | 552 | CN 266 | 92.53 |
| Invertebrate Immune Response Mechanisms | Lifetime | 841 | CN 138 | 92.79 |
| Diagnosis and treatment of tuberculosis | Lifetime | 980 | CN 29 | 90.14 |
| Histiocytic Disorders and Treatments | Lifetime | 468 | CN 13 | 89.98 |
| Kruppel-like factors research | Lifetime | 808 | CN 102 | 88.11 |
| Immune responses and vaccinations | Lifetime | 876 | CN 33 | 81.39 |
| Fractal and DNA sequence analysis | Lifetime | 615 | CN 103 | 75.84 |
| Hydrogen's biological and therapeutic effects | Lifetime | 805 | CN 244 | 72.81 |
| Cancer-related molecular mechanisms research | 2021-2025 | 29 | CN 22 | 99.65 |
| RNA modifications and cancer | 2021-2025 | 43 | CN 29 | 99.46 |
| MicroRNA in disease regulation | 2021-2025 | 50 | CN 29 | 99.18 |
| Gut microbiota and health | 2021-2025 | 102 | CN 53 | 98.92 |
| Circular RNAs in diseases | 2021-2025 | 89 | CN 66 | 97.71 |
| Metabolomics and Mass Spectrometry Studies | 2021-2025 | 159 | CN 47 | 95.34 |
| Ferroptosis and cancer prognosis | 2021-2025 | 247 | CN 197 | 96.04 |
| Cancer, Hypoxia, and Metabolism | 2021-2025 | 208 | CN 94 | 94.70 |
| Cancer Genomics and Diagnostics | 2021-2025 | 556 | CN 39 | 96.46 |
| Epigenetics and DNA Methylation | 2021-2025 | 413 | CN 156 | 94.04 |
| Esophageal Cancer Research and Treatment | 2021-2025 | 192 | CN 45 | 95.94 |
| Genomics and Phylogenetic Studies | 2021-2025 | 325 | CN 94 | 95.06 |
| RNA Research and Splicing | 2021-2025 | 289 | CN 88 | 93.63 |
| Adipose Tissue and Metabolism | 2021-2025 | 410 | CN 81 | 92.29 |
| Protein Degradation and Inhibitors | 2021-2025 | 307 | CN 43 | 93.57 |
| Cancer-related gene regulation | 2021-2025 | 260 | CN 172 | 89.72 |
| Diet and metabolism studies | 2021-2025 | 980 | CN 129 | 92.08 |
| Mycobacterium research and diagnosis | 2021-2025 | 348 | CN 47 | 90.88 |
| Renal cell carcinoma treatment | 2021-2025 | 593 | CN 69 | 92.00 |
| Birth, Development, and Health | 2021-2025 | 941 | CN 111 | 89.49 |
| Renal and related cancers | 2021-2025 | 584 | CN 68 | 86.14 |
| Genetic Mapping and Diversity in Plants and Animals | 2021-2025 | 667 | CN 228 | 87.08 |
| Mitochondrial Function and Pathology | 2021-2025 | 991 | CN 125 | 85.39 |
| RNA regulation and disease | 2021-2025 | 555 | CN 130 | 76.73 |
| Genomic variations and chromosomal abnormalities | 2021-2025 | 848 | CN 103 | 73.98 |
| Histone Deacetylase Inhibitors Research | 2021-2025 | 867 | CN 250 | 75.52 |
| Pneumocystis jirovecii pneumonia detection and treatment | 2021-2025 | 969 | CN 100 | 76.24 |
| Chromosomal and Genetic Variations | 2021-2025 | 934 | CN 240 | 75.48 |
| Trace Elements in Health | 2021-2025 | 898 | CN 344 | 73.11 |
| Hydrogen's biological and therapeutic effects | 2021-2025 | 179 | CN 84 | 69.66 |
| Plant Pathogens and Resistance | 2021-2025 | 848 | CN 171 | 66.17 |
| melanin and skin pigmentation | 2021-2025 | 993 | CN 276 | 65.84 |
| Diagnosis and treatment of tuberculosis | 2021-2025 | 805 | CN 101 | 65.31 |
| Machine Learning in Bioinformatics | 2021-2025 | 868 | CN 401 | 65.03 |
| Plant and Fungal Interactions Research | 2021-2025 | 944 | CN 268 | 60.71 |
| Research in Cotton Cultivation | 2021-2025 | 969 | CN 698 | 55.33 |
| Hydraulic flow and structures | 2021-2025 | 999 | CN 371 | 53.06 |
| Bartonella species infections research | 2021-2025 | 202 | CN 15 | 46.84 |
